NETRF funded Dr. Lynette Fernandez Cuesta to study how lung neuroendocrine tumors are classified by combining pathology with molecular data—leading to the discovery of distinct tumor subtypes, including a more aggressive form called supra-carcinoids. This new approach could help guide future treatment.

Home » NETRF funded Dr. Lynette Fernandez Cuesta to study how lung neuroendocrine tumors are classified by combining pathology with molecular data—leading to the discovery of distinct tumor subtypes, including a more aggressive form called supra-carcinoids. This new approach could help guide future treatment.